Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. - Wikidata - awgldk - TriplyDB

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.

http://www.wikidata.org/entity/Q33286516

about

LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancer Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial Transcriptional activity of c-Jun is critical for the suppression of AR function.Competing risks data analysis with high-dimensional covariates: an application in bladder cancer.Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.Shikonin inhibits the growth of human prostate cancer cells via modulation of the androgen receptor.Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.Intertwining threshold settings, biological data and database knowledge to optimize the selection of differentially expressed genes from microarray Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.Gene expression pathways of high grade localized prostate cancer.A signature inferred from Drosophila mitotic genes predicts survival of breast cancer patients Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer.Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines Usefulness of the top-scoring pairs of genes for prediction of prostate cancer progression.SNRPE is involved in cell proliferation and progression of high-grade prostate cancer through the regulation of androgen receptor expression.Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate.ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.Replication of a genome-wide case-control study of esophageal squamous cell carcinoma.Younger age is an independent predictor for poor survival in patients with signet ring prostate carcinoma.Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer.Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer Overcoming drug resistance and treating advanced prostate cancer Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.The present and future of prostate cancer urine biomarkers.Integrin alpha2beta 1 (α2β1) promotes prostate cancer skeletal metastasis.Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors.Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells.Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression.D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.Honokiol inhibits androgen receptor activity in prostate cancer cells Discovery of prostate cancer biomarkers by microarray gene expression profiling.MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer.Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer.

P2860

Q21202034-263B1085-4DEC-4152-BD19-34C1CAF6901C Q24655426-8B5ACAAF-79F7-400A-96D1-C36735A24E97 Q28534382-0109A537-5101-4C3E-8095-48113F3B03A2 Q28547130-326BB819-6C3D-4A5A-943D-0938C00E4D98 Q30412500-BC273296-2DEB-416E-96A4-2D7C526D43B7 Q30938790-85939F61-708E-4E11-8423-99D496503816 Q33557400-E78B904F-26A1-4516-AA63-EE1C830B27FB Q33637037-CBA566EF-43C7-4669-9CFD-4518AD950670 Q33724512-C0825866-C3D1-4597-94CA-127CB494105B Q33728115-87732BD1-E87F-4F89-8FED-C2703EC361C8 Q33728239-34A75D8F-73F4-41F4-891F-A2F092F2510C Q33832517-7B2AB707-95FF-4B54-9815-005645884192 Q33840749-C200F10C-2DD0-40E2-9D05-95FEF734D0D2 Q33866927-B6749A81-7CDE-44E6-AFEB-938883253AFA Q33977414-9111B7C8-8953-478C-89D5-E3055BF46B92 Q33988757-6FDA70C8-B386-4BB7-AD43-2FF338DE03D0 Q34060073-F8B7EB11-B1A5-470B-9BFB-1401A415B48B Q34319619-1687BA23-F58D-48EB-944B-DA10B0AC1494 Q34364965-93E3F27E-634B-4403-8847-83DC3A023E2E Q34411717-1E043B8D-DE2B-489C-9117-AF68FD48E83B Q34799701-E54D97BE-51E2-4293-A400-47774F89B19C Q35549861-FF889AC0-8A10-43D9-8D39-2175DC496FCA Q35836876-47026788-ECF3-44F0-9382-2404E010130A Q36241242-F4178A07-FB78-4D75-ABAA-940D69EB6063 Q36328812-85B033AF-B683-48BD-AF4E-896E54E88892 Q36685517-12304B82-F01B-46CC-B270-9474BB21F621 Q37007392-56564C67-CB4F-42C4-B51D-A799C5547AF5 Q37078560-C9762464-8162-4597-9D29-E179A9C404EF Q37103985-313D1140-6DEF-4705-8098-D26BA7E919C8 Q37146546-3203B37C-B1A8-4F68-B61F-B256358DAB96 Q37270422-ED44D4EC-53AC-41F5-B695-5AC160DD18EE Q37285917-63B58657-68CA-4437-B9F6-04E6EA6C09DF Q37400784-7EC2084C-BA17-4F63-9D0E-D08F8060BC27 Q37426675-75A02D9F-9763-4A59-A413-F434306D23FE Q37445211-030DEEFF-7A04-4DC3-9D60-098F081A442E Q37625379-898514E1-4EF4-45F4-A7CB-9BD473980779 Q37656262-A15BB478-CADC-41C0-A05E-C68364DFF541 Q37688166-68EF6D16-5EFE-4965-A9FA-4168F1F80D8B Q37701551-278E2751-2EBC-46C0-B31F-AFEAB6D7074E Q37818297-B8E4042E-483E-4B7A-AAE8-9E6100A936E4

P2860

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.

http://www.wikidata.org/entity/Q33286516

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Molecular features of hormone- ...... wide gene expression profiles.

@ast

Molecular features of hormone- ...... wide gene expression profiles.

@en

type

label

Molecular features of hormone- ...... wide gene expression profiles.

@ast

Molecular features of hormone- ...... wide gene expression profiles.

@en

prefLabel

Molecular features of hormone- ...... wide gene expression profiles.

@ast

Molecular features of hormone- ...... wide gene expression profiles.

@en

P1433

Q33286516-EEABB8DE-23B7-444D-B98E-45A302749EBA

P1476

Q33286516-3C06A459-34B2-413D-AEF4-3FDC12384FB7

P2093

Q33286516-20A5B47A-9EE5-4FFB-861F-50E4B49608B5

Q33286516-243B4E67-99C0-4A6E-AF6B-79B018ED0A4D

Q33286516-2505E778-FF8D-4EB6-8E4B-4431F703B268

Q33286516-3534BA11-0C46-4F7E-BDA0-852C58623C31

Q33286516-35C06674-42BD-4FCE-8234-E4DC0A9AD034

Q33286516-4EE10B8B-42E1-4DD6-9FC4-7CAB1B09DF91

Q33286516-520A8E20-DF7C-4A89-B500-177300F5A23D

Q33286516-59CEA13E-E7D8-4981-A6D5-F530DF401173

Q33286516-6EE186B0-7607-441B-ABC7-4019920B5DB8

Q33286516-6F90405E-A77C-43F2-B2CC-22DDA3DDA0B0

P304

Q33286516-97628AE0-BEE1-4CC2-8109-2A3DD17803D9

P31

Q33286516-0E5E2DD6-7A3A-405F-A4EA-A05A2317C62E

P356

Q33286516-8C7B9849-9DA8-47AE-920A-2DED6FB29220

P407

Q33286516-2D1CC849-D23F-4399-819B-9A06235FB53F

P433

Q33286516-C0F4141F-1172-48BC-985F-2151CC204049

P478

Q33286516-24A733B0-2742-435F-85EC-B3741A6C0B7E

P577

Q33286516-A763707F-AD1C-4F32-B9A9-410A620512F3

P5875

Q33286516-5539195D-9E61-403D-ABCC-945DED5A58FB

P698

Q33286516-BA8BAEDB-26ED-49E2-A875-80129A47F41F

P356

0008-5472.CAN-06-4040

P1433

Cancer Research

P1476

Molecular features of hormone- ...... wide gene expression profiles.

@en

P2093

Hidewaki Nakagawa

http://www.w3.org/2001/XMLSchema#string

Hideyuki Akaza

http://www.w3.org/2001/XMLSchema#string

Hiroki Yoshioka

http://www.w3.org/2001/XMLSchema#string

Hiromi Kumon

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Konaka

http://www.w3.org/2001/XMLSchema#string

Keiichi Tozawa

http://www.w3.org/2001/XMLSchema#string

Kenji Tamura

http://www.w3.org/2001/XMLSchema#string

Kenjiro Kohri

http://www.w3.org/2001/XMLSchema#string

Masayoshi Yokoyama

http://www.w3.org/2001/XMLSchema#string

Mikio Namiki

http://www.w3.org/2001/XMLSchema#string

P304

5117-5125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-06-4040

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6290164

http://www.w3.org/2001/XMLSchema#string

P698

17545589

http://www.w3.org/2001/XMLSchema#string